Business Context and Reporting Period
Company: McKesson Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: October 23, 2013
Event: Entry into a Material Definitive Agreement and Creation of a Direct Financial Obligation.
On October 24, 2013, McKesson Corporation and its subsidiary Dragonfly GmbH & Co. KGaA entered into a Share Purchase Agreement (SPA) with Franz Haniel & Cie. GmbH and a Business Combination Agreement (BCA) with Celesio AG. McKesson intends to acquire Haniel's 50.01% majority stake in Celesio and launch voluntary public tender offers for the remaining shares.
Key Financial Metrics and Transaction Value
- Total Transaction Value: Approximately €6.1 billion (including assumption of Celesio's outstanding debt).
- USD Equivalent: Approximately $8.3 billion (based on an exchange rate of $1.35/€1).
- Share Purchase Price: €23 per share for Haniel's stake.
- Financing Facility: $5.5 billion 364-day unsecured Senior Bridge Term Loan Agreement.
- Debt Covenant: McKesson must maintain a debt-to-capital ratio of no greater than 65% during the term of the Bridge Loan.
Material Changes and Transaction Structure
The filing details a significant expansion of McKesson's European operations through the acquisition of Celesio AG. The transaction structure involves:
- Acquisition Mechanism: Purchase of Haniel's stake plus parallel tender offers for remaining shares and convertible bonds.
- Financing Strategy: Utilization of the new $5.5 billion bridge loan and cash on hand. The company expects to refinance this bridge loan with longer-term financing prior to the 364-day maturity.
- Conditions Precedent: The SPA may be terminated if antitrust approval is not received or if McKesson fails to acquire at least 75% of Celesio's shares on a fully diluted basis.
Guidance, Risks, and Contingencies
Management Commentary and Intent: McKesson intends to complete the acquisition to expand its business, with the BCA outlining terms for Celesio's operation post-closing. The BCA expires in twenty-four months.
Risks and Contingencies:
- Regulatory Risk: The transaction is contingent upon receiving applicable antitrust approvals.
- Ownership Threshold Risk: The tender offers are conditional on acquiring at least 75% of Celesio's fully diluted shares; otherwise, McKesson is not obligated to acquire shares submitted during the offers.
- Financial Covenants: The Bridge Loan Agreement imposes limitations on creating liens, engaging in certain mergers, and entering swap contracts, alongside the 65% debt-to-capital ratio requirement.
- Refinancing Risk: The company relies on securing permanent financing to replace the bridge loan before its maturity.
Investor Verification Checklist
- Verify the status of antitrust approvals required for the Celesio acquisition.
- Monitor the progress of the tender offers to ensure the 75% ownership threshold is met.
- Review the terms of the permanent financing expected to replace the $5.5 billion bridge loan.
- Assess the impact of the assumed Celesio debt on McKesson's overall leverage and ability to maintain the 65% debt-to-capital ratio.
- Examine the full text of the Share Purchase Agreement (Exhibit 10.1) and Business Combination Agreement (Exhibit 10.2) for additional termination rights or conditions.